Little old Betaville notes that arch rivals at Bloomberg have revealed that France's Sanofi was the rival bidder in talks to buy Reata Pharmaceuticals, the US-listed biopharmaceutical company.
Below is a link to that piece:..
Biogen, a US-listed pharmaceutical giant, has now announced the purchase of Reata Pharmaceuticals Inc for $7.3 billion. Below is a link to today's press release.
Little old Betaville wonders, though, whether Reata's other rumoured suitor (see Part 1) will step out of the shadows?
Or will Biogen's offer prove to be a knock out?..
Oh look - Bloomberg have followed up yesterday's UNCOOKED alert about a potential takeover of Reata Pharmaceuticals Inc, the US-listed biopharmaceutical company.
Arch rivals at Bloomie are reporting that Biogen is one of the company's considering an offer for Reata Pharmaceuticals Inc.....